Emilie Alirol started to work with DNDi in August 2016, joining the Global Antibiotics Research and Development Partnership (GARDP) as a Project Advisor. In January 2017 she transitioned to a Senior Clinical Trial Manager position, working on both the Sexually Transmitted Infections (STIs) and Neonatal sepsis programs. Since 2018, Emilie Alirol is leading the STI program. Prior to this, she worked as Clinical Trial Manager of an MSF-sponsored trial on Multi-Drug Resistant Tuberculosis (MDR-TB).
Emilie obtained her PhD in molecular biology from the University of Geneva in 2006. She also holds a Masters of Science in Epidemiology from the London School of Hygiene and Tropical Medicine (LSHTM). She started her career as a Clinical Research Scientist with the Geneva University Hospitals, where she focused on infectious diseases research. She has been involved in both therapeutic and diagnostic studies, and has managed several investigator-initiated trials, from phase 2 to 4. Since 2011 Emilie has also been engaged in training and education on clinical trials.
Emilie was an Ethics Committee member for 6 years and the vice chair of the WHO Research Ethics Review Committee from 2014 to 2017.